期刊文献+

枳桔二陈汤辅助治疗儿童迁延性细菌性支气管炎44例临床观察 被引量:3

The clinical efficacy of Zhijie Erchen Tang in adjunctive treatment of 44 cases of protracted bacterial bronchitis in children
原文传递
导出
摘要 目的探讨枳桔二陈汤辅助治疗儿童迁延性细菌性支气管炎的临床疗效。方法将2013年12月至2016年6月于我院儿科确诊为儿童迁延性细菌性支气管炎的86例患儿随机分为对照组42例和治疗组44例,对照组采用阿莫西林克拉维酸钾静脉滴注治疗,治疗组在对照组治疗方法的基础上给予枳桔二陈汤口服,治疗14 d后统计2组的临床疗效及不良反应发生情况。结果 2组治疗前CD_3^+,CD_4^+,CD_4^+/CD_8^+免疫指标水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后2组上述指标均明显升高,与同组治疗前比较差异有统计学意义(P<0.05),且治疗组升高幅度大于对照组(P<0.05)。治疗组咳嗽、气喘、湿啰音、哮鸣音消失时间均较对照组短,经统计学分析,差异均有统计学意义(P<0.05)。对照组总有效率为73.81%,治疗组为93.19%,经统计学分析,差异有统计学意义(P<0.05)。对照组总不良反应发生率为26.19%,治疗组为9.91%,经统计学分析,差异有统计学意义(P<0.05)。结论枳桔二陈汤辅助治疗儿童迁延性细菌性支气管炎,可明显提高患儿的免疫功能,缩短病程,疗效显著。 Objective To explore the clinical efficacy of Zhiju Erchen Tang in adjunctive treatment of 44 cases of protracted bacterial bronchitis in children. Methods 84 cases of children with protracted bacterial bronchitis from December 2013 to June 2016 in our hospital were randomized into therapy group (44 cases) and control group (42 cases). The control group was treated with intravenous drip of Amoxicillin Sodium and Clavulanate Potassium, while the therapy group was given Zhijie Erchen Tang by oral administration based on the therapy of control group. After treated for 14 days, the clinical effects and untoward effects of two groups were observed. Results Before treatment,there were no significant differences in the levels of CD3+, CD4, CD4/CD8+ of two groups (P〉0.05) ;They were much higher in two groups than that before treatment with significant differences ( P 〈 0.05 ) , and the increa- sing amplitude in therapy group was significantly greater than that in control group ( P〈0.05 ). The disappearance time of asthma,cough,crackles and wheezing were shorter with statistically significant differences (P〈0.05). The total effective rate in therapy group and control group was 93.19% and 73.81% respectively, differences were significant (P〈0.05). The incidence rate of adverse reaction was 26.19% in control group,9.91% in therapy group with significant differences (P〈0.05). Conclusion Zhijie Erchen Tang, as an adjunctive therapy, can treat children with protracted bacterial bronchitis effectively by enhancing immunity and promoting disease rehabilitation, which is worthy of clinical promotion.
出处 《中医儿科杂志》 2017年第3期38-41,共4页 Journal of Pediatrics of Traditional Chinese Medicine
关键词 迁延性细菌性支气管炎 儿童 枳桔二陈汤 临床观察 protracted bacterial bronchitis children Zhijie Erchen Tang clinical observation
  • 相关文献

二级参考文献25

  • 1袁林,杨永弘,王艳,张美和,甄景慧,沈叙庄.儿童携带卡他莫拉菌的耐药性及bro基因分型研究[J].实用儿科临床杂志,2005,20(5):423-426. 被引量:2
  • 2王传清,王艺,王晓红,王爱敏,何磊燕,宋建明,薛建昌,沈叙庄,杨永弘.2000至2006年复旦大学附属儿科医院呼吸道感染患儿4种常见细菌分离率及耐药趋势[J].中国循证儿科杂志,2007,2(3):197-204. 被引量:15
  • 3中华医学会儿科学分会呼吸学组.《中华儿科杂志》编辑委员会,儿童慢性咳嗽诊断与治疗指南.中华儿科杂志,2008,:104-107.
  • 4Bootsma HJ, van Dijk H, Vauterin P, et al. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation mediated horizontal transfer [J]. Mol Micro- biol, 2000, 36(1): 93-104.
  • 5du Plessis M. Rapid discrimination between BRO beta-lacta- mases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis [J]. Diagn Microbiol Infect Dis, 2001, 39(1): 65-67.
  • 6Bell JM, Tumidge JD, Jones RN. Development of a disk dif- fusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program report [J]. J Clin Microbiol, 2009, 47(7): 2187-2193.
  • 7Volkov IK, Katosova LK, Shcherbakova NIU, et al. Mo- raxella catarrhalis in chronic and relapsing respiratory tract infections in children [J]. Antibiot Khimioter, 2004, 49(8-9): 43-47[Russian].
  • 8Khan MA, Northwood JB, Levy F, et al. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults [J]. J Antimi-erob Chemother, 2010, 65(1): 91-97.
  • 9Verduin CM, Hol C, Fleer A, et al. Moraxella catarrhalis: from emerging to .established pathogen [J]. Clin Microbiol Rev, 2002, 15(1): 125-144.
  • 10Schmitz FJ, Beeck A, Perdikouli M, et al. Production of BRO lactamase and resistance to complement in European Morax- elle catarrhalis isolates [J]. J Clin Microbiol, 2002, 40(4): 1546-1548.

共引文献37

同被引文献21

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部